SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is trending as investors monitor technical indicators for a potential breakout, with the community actively debating whether it is positioned for a significant rally alongside broader crypto market momentum. While some traders express frustration with current price consolidation, many are highlighting historical patterns and potential institutional adoption as catalysts for future growth.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is seeing significant engagement as traders debate its long-term potential amid a broader crypto market rotation into AI and IoT-related narratives. While some in the community are actively accumulating, others are voicing frustration over stagnant price action and expressing skepticism regarding project leadership and ecosystem partnerships.

Fartcoin is a meme-driven cryptocurrency where users can submit their best fart jokes or memes to earn initial tokens. Each transaction triggers a hilarious 'Gas Fee' effect, complete with a digital fart sound for maximum comedic impact.

Fartcoin

Fartcoin is seeing increased community engagement as traders speculate on its price trajectory and potential for a breakout, often drawing comparisons to other speculative assets. The conversation is heavily driven by its active social media presence, with proponents highlighting its status as a meme coin and its frequent inclusion in broader crypto trend discussions.

TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.

TransCode Therapeutics Inc

TransCode Therapeutics is currently seeing intense activity following a strategic acquisition of Polynoma and a significant equity infusion, which investors are weighing against concerns regarding dilution and the company's past history of reverse splits. Community discussion is heavily focused on whether this financing provides the necessary runway for their metastatic cancer drug, TTX-MC138, to finally demonstrate efficacy in upcoming Phase 2 trials.

$ORDI : first token deployed on Bitcoin Ordinals, with a 21 million supply. $DOGI : first token deployed on Dogecoin Ordinals, with a 21 million supply. The First DRC-20 token in the history

dogi

DOGI is gaining momentum as the first DRC-20 token on the Dogecoin network, with community members actively accumulating the asset alongside Dogecoin. Traders are highlighting the upcoming launch of Doge OS and rising transaction volumes as key catalysts driving sentiment around the project's utility and market potential.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

The MullenArmy community is actively attempting to revitalize interest in their crypto token, frequently citing its past market cap highs and the potential for a new parabolic rally. While proponents encourage buyers to hold through volatility and rotate profits from other assets, skeptics continue to warn of historical pump-and-dump patterns and the token's lack of fundamental utility.

BIO is a curation and liquidity protocol for Decentralized Science (DeSci). Our mission is to accelerate biotechnology by giving global communities of patients, scientists and biotech professionals the ability to collectively fund, build and own tokenized biotech projects and intellectual property (IP).   The team behind BIO helped create Molecule, a tokenization platform for early-stage biomedicine, and VitaDAO, the largest decentralized community for longevity science. Building on these successes, BIO is designed to catalyze an onchain scientific economy through decentralized funding, incentives and liquidity.  The BIO token gives holders access to BIO's network of scientific communities and IP, enabling broad exposure to the DeSci economy.

Bio Protocol

Bio Protocol is capturing attention following its recent listing on Coinbase and excitement surrounding its V2 upgrade, which includes new staking rewards. Community sentiment is highly bullish as investors draw comparisons to other high-momentum tokens, actively debating potential price breakouts and the long-term potential of the DeSci sector.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy is trending as the community debates its long-term potential and utility amidst a challenging price environment. While some investors express frustration over recent performance, others are actively accumulating tokens, holding onto the belief that the project will eventually see a significant recovery.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is generating significant community conversation as traders weigh its technical breakout potential against a broader market rotation, with many investors closely watching for a sustained move past key support levels. Discussions are currently dominated by a mix of bullish sentiment regarding ecosystem utility and the active promotion of long-standing community projects built on the network.

Brinker International, Inc. engages in owning, developing, and franchising Chili's Grill and Bar and Maggiano's Little Italy restaurant brands. It operates through the Chili's and Maggiano's segments. The Chili's segment includes the results of company-owned Chili's restaurants in the U.S. and Canada as well as the results from its domestic and international franchise business. The Maggiano's segment refers to the results of company owned Maggiano's restaurants. The company was founded by Larry Lavine on March 13, 1975 and is headquartered in Dallas, TX.

Brinker International, Inc.

Brinker International, Inc. (EAT) has emerged as a standout performer in the restaurant sector, with investors pointing to robust same-store sales growth, traffic gains at Chili's, and successful menu innovation as key drivers behind the stock's recent momentum. The community is actively discussing the company's operational execution and its ability to maintain value-oriented appeal, though some participants remain cautious, debating the sustainability of current valuation levels and potential macro headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The company said its NOOR Collagen supplement is projected to generate over $12 million in annualized revenue.</li><li>Cosmos said the impact on operations due to the Middle East conflict is negligible.</li><li>The firm is in the process of acquiring a Greece-based pharmacy distribution network.</li></ul>Cosmos Health Inc (COSM) drew retail attention on Thursday after the company said it is exploring potential capital-raising options, including monetizing non-core assets, to address what it described as a “valuation disconnect”.The company said its shares are currently trading well below book value, adding that its market capitalization does not fully reflect the strength of its operations or the value of its diversified asset base. Management said it may use proceeds to support strategic investments, acquisitions, and possible share buybacks.<a href="https://stocktwits.com/symbol/COSM">COSM shares</a> were up around 3% at $0.3. The company has a price-to-book ratio of 0.67 compared to the industry average of 4.48, according to Investing.com.<h2 class="st-heading-2">Cosmos’ Sky Premium Life Brand To Generate 75% Gross Margin</h2>Cosmos Health expects gross margins of around 75% and strong cash flow from its U.S. operations for the Sky Premium Life brand. Sky Premium sells nutraceuticals, vitamins, and food supplements. The company said its NOOR Collagen supplement alone is projected to generate over $12 million in annualized revenue.The company stated it is actively advancing its acquisition strategy, highlighted by a recent letter of intent to acquire a Greece-based pharmacy distribution network generating approximately $11.5 million in annual revenue. The move supports the company’s broader plan to scale operations and achieve its 2027 revenue target of $155.8 million.Cosmos Health also said that the recent global geopolitical conflict has had a negligible impact on its operations.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits turned ‘bullish’ from ‘neutral’ a day earlier, but chatter was mixed. One user expects a 90% to 95% increase in the stock’s price from its record lows of $0.28.<stembedurl>https://stocktwits.com/Letsgetpd/message/648003039</stembedurl>Another user said the stock has plenty of room to continue falling.<stembedurl>https://stocktwits.com/Stopcryin/message/647973933</stembedurl>The stock has been under selling pressure so far this year, with shares down around 35%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/humacyte-secures-saudi-order-why-did-huma-stock-crash-to-record-low/cZ3ao9nRIhh">Humacyte Secures $1.5M Saudi Order – Why Did HUMA Stock Crash To Record Low Today?</a> For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a stock chart on black background. | Image source: Getty Images

This Nano Cap Pharmaceutical Company Flags ‘Valuation Disconnect’ –  But Retail Sees Upto 95% Upside From Record Lows

Cosmos Health expects gross margins of around 75% and strong cash flow from the U.S. operations of its Sky Premium Life brand

COSM Stock In Spotlight As Company Explores Raising Capital To Address ‘Valuation Disconnect’  

Equity

Grigorios Siokas Acquires 388,532 Shares of Cosmos Health (NASDAQ:COSM) Stock

Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas acquired 388,532 shares of the stock in a transaction dated Thursday, February 12th. The shares were bought at an average cost...

Cosmos Health (NASDAQ:COSM) CEO Buys $119,417.42 in Stock

Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas purchased 291,262 shares of the stock in a transaction that occurred on Wednesday, February 11th. The stock was acquired at an...

Cosmos Health (NASDAQ:COSM) CEO Purchases $176,660.50 in Stock

Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas acquired 353,321 shares of Cosmos Health stock in a transaction on Tuesday, January 20th. The shares were bought at an average...

Grigorios Siokas Buys 493,495 Shares of Cosmos Health (NASDAQ:COSM) Stock

Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas purchased 493,495 shares of the firm's stock in a transaction on Wednesday, January 14th. The shares were acquired at an...

Cosmos Health (NASDAQ:COSM) CEO Acquires $43,273.86 in Stock

Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas bought 88,314 shares of the stock in a transaction dated Friday, December 19th. The shares were purchased at an average cost of...

Cosmos Health (NASDAQ:COSM) CEO Grigorios Siokas Acquires 168,472 Shares

Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas acquired 168,472 shares of the business's stock in a transaction that occurred on Monday, December 15th. The shares were bought...

Grigorios Siokas Purchases 76,360 Shares of Cosmos Health (NASDAQ:COSM) Stock

Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas acquired 76,360 shares of the business's stock in a transaction dated Friday, November 28th. The stock was acquired at an...

Insider Buying: Cosmos Health (NASDAQ:COSM) CEO Buys $35,111.16 in Stock

Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas bought 55,732 shares of the stock in a transaction that occurred on Tuesday, November 25th. The shares were bought at an...

Grigorios Siokas Buys 51,315 Shares of Cosmos Health (NASDAQ:COSM) Stock

Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas purchased 51,315 shares of Cosmos Health stock in a transaction on Thursday, November 20th. The stock was bought at an average...

Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. It is also involved in the research and development of its business units, and acquisition of pharmaceutical companies. The firm offers over-the-counter drugs, branded and generic medicines, and dietary and vitamin supplements. The company was founded on July 21, 2009 and is headquartered in Thessaloniki, Greece.

Cosmos Health Inc

Up > 1%

Flat +/- 1%

Down > 1%

Where does the $SPY finish next week vs. Friday’s close?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.04	--	--	N/A
Q3 '25	--	-$0.53	--	N/A
Q4 '24	-$0.09	--	--	N/A
Q3 '24	-$0.11	-$0.45	-309.09%	MISSED
Q2 '24	-$0.14	--	--	N/A

COSM
Cosmos Health Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest COSM News

COSMCosmos Health Inc.